top of page

Relationship of early-onset baldness to prostate cancer in African-American men

Charnita Zeigler-Johnson, Knashawn H Morales, Elaine Spangler, Bao-Li Chang, Timothy R Rebbeck


First published: April 2013

PMID: 23532004 PMCID: PMC3617056 DOI: 10.1158/1055-9965.EPI-12-0944


Abstract

Background: Early-onset baldness has been linked to prostate cancer; however, little is known about this relationship in African-Americans who are at elevated prostate cancer risk.


Methods: We recruited 219 African-American controls and 318 African-American prostate cancer cases. We determined age-stratified associations of baldness with prostate cancer occurrence and severity defined by high stage (T3/T4) or high grade (Gleason 7+.) Associations of androgen metabolism genotypes (CYP3A4, CYP3A5, CYP3A43, AR-CAG, SRD5A2 A49T, and SRD5A2 V89L), family history, alcohol intake, and smoking were examined by baldness status and age group by using multivariable logistic regression models.


Results: Baldness was associated with odds of prostate cancer [OR = 1.69; 95% confidence interval (CI), 1.05-2.74]. Frontal baldness was associated with high-stage (OR = 2.61; 95% CI, 1.10-6.18) and high-grade (OR = 2.20; 95% CI, 1.05-4.61) tumors. For men diagnosed less than the age of 60 years, frontal baldness was associated with high stage (OR = 6.51; 95% CI, 2.11-20.06) and high grade (OR = 4.23; 95% CI, 1.47-12.14). We also observed a suggestion of an interaction among smoking, median age, and any baldness (P = 0.02).


Conclusions: We observed significant associations between early-onset baldness and prostate cancer in African-American men. Interactions with age and smoking were suggested in these associations. Studies are needed to investigate the mechanisms influencing the relationship between baldness and prostate cancer in African-American men.


Impact: African-American men present with unique risk factors including baldness patterns that may contribute to prostate cancer disparities.



Please contact us if you are having difficulty accessing the full PDF of this or any MADCaP publication.

Recent Posts

See All

Comments


© Copyright 2016-2022 

Dana-Farber Cancer Institute.

Use of MADCaP is subject to our terms of use and our privacy policy.

MADCaP Network
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

Supported by Dana-Farber Cancer Institute

MADCaP is grant-funded by the National Cancer Institute

NCI_Stacked_COLOR.png
img-logo-2x-new.png
bottom of page